Team:Freiburg/Results/Summary

From 2014.igem.org

(Difference between revisions)
Line 43: Line 43:
{{:Team:Freiburg/Templates/html/js.html}}
{{:Team:Freiburg/Templates/html/js.html}}
<html>
<html>
 +
<script>
 +
    // hover over effects
 +
    (function(){
 +
      var left = $('#over-left'),
 +
        right = $('#over-right'),
 +
        links = $('#svg-schema-overview svg a');
 +
        console.dir(links);
 +
      function onHover(){
 +
        console.log("hovering");
 +
        // grab content
 +
        var content = $($(this).data('id'));
 +
 +
        // set content
 +
        var target = content.data('target');
 +
        console.dir(content);
 +
        console.dir(target);
 +
        if (target == '#over-right') right.html(content.html());
 +
        if (target == '#over-left') left.html(content.html());
 +
      };
 +
 +
      function onBlur(){
 +
        // clear content
 +
        right.html('');
 +
        left.html('');
 +
      }
 +
 +
      // add hover/blur handler
 +
      links.hover(onHover, onBlur);
 +
    })();
 +
  </script>
<script>
<script>
// set title  
// set title  

Revision as of 16:33, 17 October 2014

The AcCELLerator

Summary



We, the iGEM Team Freiburg 2014, have the goal to combine the capability of viral vectors for stable gene transfer with the spatio-temporal resolution of optogenetics for gene delivery into mammalian cells. We utilized the Murine Leukemia Virus (MuLV) that specifically uses the murine mCAT-1 receptor to infect target cells. By using a blue light inducible expression system, we brought the receptor to the plasma membrane of illuminated cells to enable targeted gene delivery by the virus.

Our project was quite a large success! We:

  • produced MuLV viruses containing different reporter proteins,
  • optimized MuLV production and transduction protocols to reach close to 100% efficiency,
  • created stable mammalian cell lines using the MuLV virus,
  • generated patterns of reporter proteins in cell cultures by light exposure,
  • demonstrated that the virus exclusively infects cells expressing the mCAT-1 receptor,
  • infected cells with the MuLV virus that expressed the mCAT-1 receptor after light induction.

We provide the virus as a tool for the generation of stable mammalian cell lines under biosafety level 1 regulations. Our viral vector, which we propose as a new iGEM RFC, enables the user to introduce any gene of interest stably into mammalian cell lines. Therefore we provide for the iGEM community a fast, easy to handle and safe way of generating stable cell lines.

During the course of iGEM, we learned many new techniques:

  • mammalian cell culture,
  • fluorescence activated cell sorting,
  • virus production under biosafety level 1 and biosafety level 2 conditions,
  • many different cloning techniques,
  • widefield and confocal microscopy,
  • creating a website,

and, last but not least, we had a lot of fun and learned how to work together as a team!